loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Eprosartan Mesylate, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Eprosartan Mesylate

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    With Fermion, start the journey of your innovative API.

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    2D Structure
    1. Also known as: 144143-96-4, Teveten, Eprosartan mesilate, Eprosartan methanesulfonate, Eprosartan monomethanesulfonate, Eprosartan (mesylate)
    Molecular Formula
    C24H28N2O7S2
    Molecular Weight
    520.6  g/mol
    InChI Key
    DJSLTDBPKHORNY-XMMWENQYSA-N
    FDA UNII
    8N2L1NX8S3
    Eprosartan Mesylate is the mesylate salt form of eprosartan, a non-biphenyl, non-tetrazole, nonpeptide angiotensin II antagonist with antihypertensive activity. Eprosartan mesylate antagonizes angiotensin II type I receptors in tissues such as vascular smooth muscle and the adrenal gland. This prevents angiotensin II-induced vasoconstriction and prevents angiotensin II-mediated stimulation of aldosterone secretion by the adrenal cortex, which decreases the excretion of sodium and water and increases the excretion of potassium.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid;methanesulfonic acid
    2.1.2 InChI
    InChI=1S/C23H24N2O4S.CH4O3S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27;1-5(2,3)4/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29);1H3,(H,2,3,4)/b18-12+;
    2.1.3 InChI Key
    DJSLTDBPKHORNY-XMMWENQYSA-N
    2.1.4 Canonical SMILES
    CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O.CS(=O)(=O)O
    2.1.5 Isomeric SMILES
    CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O.CS(=O)(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    8N2L1NX8S3
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-thiophenepropanoic Acid, Alpha-((2-butyl-1-((4- Carboxyphenyl)methyl)-lh-imidazol-5-yl)methylene)-, (e)-

    2. Eprosartan

    3. Sk And F 108566

    4. Skf-108566

    5. Teveten

    2.3.2 Depositor-Supplied Synonyms

    1. 144143-96-4

    2. Teveten

    3. Eprosartan Mesilate

    4. Eprosartan Methanesulfonate

    5. Eprosartan Monomethanesulfonate

    6. Eprosartan (mesylate)

    7. Sk&f 108566-j

    8. Sk&f-108566-j

    9. 8n2l1nx8s3

    10. Chebi:48409

    11. (e)-2-butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate

    12. 4-[[2-butyl-5-[(e)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic Acid;methanesulfonic Acid

    13. Eprosartan Mesylate (usan)

    14. Dsstox_cid_24217

    15. Dsstox_rid_80124

    16. Dsstox_gsid_44217

    17. Eprosartan Mesylate [usan]

    18. 4-({2-butyl-5-[(1e)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1h-imidazol-1-yl}methyl)benzoic Acid; Methanesulfonic Acid

    19. Cas-144143-96-4

    20. Eprosartan Mesylate [usan:ban]

    21. Ncgc00164557-01

    22. Unii-8n2l1nx8s3

    23. Futuran

    24. Navixen

    25. Regulaten

    26. Tevetenz

    27. Epro-sartan Mesylate Dihydrate

    28. Sr-05000001450

    29. Eprosartanmesylate

    30. Teveten Sb

    31. Skf-108566j

    32. Teveten (tn)

    33. Schembl41396

    34. Chembl1200987

    35. Dtxsid7044217

    36. Hms3262b17

    37. Hms3885b05

    38. Eprosartan Mesylate [vandf]

    39. Eprosartan Mesilate [mart.]

    40. Tox21_112186

    41. Tox21_500808

    42. Eprosartan Mesilate [who-dd]

    43. Eprosartan Mesylate [usp-rs]

    44. Hy-15834a

    45. Mfcd08141807

    46. S4102

    47. Akos015994738

    48. Eprosartan Mesylate, >=98% (hplc)

    49. Tox21_112186_1

    50. Am84399

    51. Ccg-222112

    52. Ks-1233

    53. Eprosartan Mesylate [orange Book]

    54. Ncgc00167505-02

    55. Ncgc00261493-01

    56. (e)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1h-imidazol-1-yl)methyl)benzoic Acid Compound With Methanesulfonic Acid (1:1)

    57. 2-thiophenepropanoic Acid, Alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-, (e)-, Monomethanesulfonate

    58. Eprosartan Mesylate [usp Monograph]

    59. Eprosartan Monomethanesulfonate [mi]

    60. E-145

    61. E1161

    62. Sw219286-1

    63. A13747

    64. D02082

    65. Teveten Hct Component Eprosartan Mesylate

    66. 143e964

    67. A808180

    68. Eprosartan Mesylate Component Of Teveten Hct

    69. J-007923

    70. Sr-05000001450-2

    71. Q27121190

    72. Eprosartan Mesylate, United States Pharmacopeia (usp) Reference Standard

    73. (e)-2-butyl-1-(p-carboxybenzyl)-.alpha.-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate

    74. (e)-2-butyl-1-(p-carboxybenzyl)-.alpha.-2-thenylimidazole-5-acrylic Acid, Monomethanesulphonate

    75. (e)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1h-imidazol-1-yl)methyl)benzoic Acid Methanesulfonic Acid Salt

    76. (e)-alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-2-thiophenepropanoic Acid Monomethanesulfonate

    77. 2-thiophenepropanoic Acid, .alpha.-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-, (e)-, Monomethanesulfonate

    78. 2-thiophenepropanoic Acid, .alpha.-((2-butyl-1-((4-carboxyphenyl)methyl)-1h-imidazol-5-yl)methylene)-, (e)-, Monomethanesulphonate

    79. 2-thiophenepropanoic Acid, Alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1h-imidazol-5-yl]methylene]-, (alphae)-, Methanesulfonate (1:1)

    80. 4-({2-butyl-5-[(1e)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1h-imidazol-1-yl}methyl)benzoic Acid Methanesulfonate

    81. 4-[[2-butyl-5-[(e)-2-carboxy-3-(2-thienyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic Acid; Methanesulfonic Acid

    82. 4-[[2-butyl-5-[(e)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic Acid;methanesulfonic Acid.

    83. Eprosartan Mesylate

    84. Sk&f 108566

    85. (?e)-?-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1h-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid Methanesulfonate

    2.4 Create Date
    2005-10-11
    3 Chemical and Physical Properties
    Molecular Weight 520.6 g/mol
    Molecular Formula C24H28N2O7S2
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count10
    Exact Mass520.13379358 g/mol
    Monoisotopic Mass520.13379358 g/mol
    Topological Polar Surface Area183 Ų
    Heavy Atom Count35
    Formal Charge0
    Complexity711
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 4  
    Drug NameEprosartan mesylate
    PubMed HealthEprosartan (By mouth)
    Drug ClassesCardiovascular Agent, Renal Protective Agent
    Drug LabelTEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl...
    Active IngredientEprosartan mesylate
    Dosage FormTablet
    RouteOral
    Strengtheq 600mg base; eq 400mg base
    Market StatusPrescription
    CompanyMylan Pharms

    2 of 4  
    Drug NameTeveten
    Drug LabelTEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl...
    Active IngredientEprosartan mesylate
    Dosage FormTablet
    RouteOral
    Strengtheq 600mg base; eq 400mg base
    Market StatusPrescription
    CompanyAbbvie

    3 of 4  
    Drug NameEprosartan mesylate
    PubMed HealthEprosartan (By mouth)
    Drug ClassesCardiovascular Agent, Renal Protective Agent
    Drug LabelTEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl...
    Active IngredientEprosartan mesylate
    Dosage FormTablet
    RouteOral
    Strengtheq 600mg base; eq 400mg base
    Market StatusPrescription
    CompanyMylan Pharms

    4 of 4  
    Drug NameTeveten
    Drug LabelTEVETEN (eprosartan mesylate) is a non-biphenyl non-tetrazole angiotensin II receptor (AT1) antagonist. A selective non-peptide molecule, TEVETEN is chemically described as the monomethanesulfonate of (E )-2-butyl-1-(p-carboxybenzyl)--2-thienyl...
    Active IngredientEprosartan mesylate
    Dosage FormTablet
    RouteOral
    Strengtheq 600mg base; eq 400mg base
    Market StatusPrescription
    CompanyAbbvie

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    Angiotensin II Type 2 Receptor Blockers

    Agents that antagonize the ANGIOTENSIN II TYPE 2 RECEPTOR. (See all compounds classified as Angiotensin II Type 2 Receptor Blockers.)

    Post Enquiry
    POST ENQUIRY